logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Developments In T Cell Based Cancer Immunotherapies Paolo A Ascierto

  • SKU: BELL-5255746
Developments In T Cell Based Cancer Immunotherapies Paolo A Ascierto
$ 31.00 $ 45.00 (-31%)

4.3

78 reviews

Developments In T Cell Based Cancer Immunotherapies Paolo A Ascierto instant download after payment.

Publisher: Humana Press
File Extension: PDF
File size: 8.84 MB
Pages: 316
Author: Paolo A. Ascierto, David F. Stroncek, Ena Wang (eds.)
ISBN: 9783319211664, 3319211668
Language: English
Year: 2015

Product desciption

Developments In T Cell Based Cancer Immunotherapies Paolo A Ascierto by Paolo A. Ascierto, David F. Stroncek, Ena Wang (eds.) 9783319211664, 3319211668 instant download after payment.

This volume illustrates the salient aspects of cancer biology relevant to the successful implementation of immunotherapy. Topics include enhancement of antigen-specific immune responses by anti-cancer vaccines, modulation of the function of T cells within the tumor microenvironment, and the effects of genetic, epigenetic, developmental, and environmental determinants on T cell function. Other topics covered include the ex vivo expansion of T or other immune cells and their genetic modification or reprogramming to increase their ability to survive and expand when adoptively transferred back to the patients. Specific attention is devoted to the genetic manipulation of T cells through the introduction of re-directed T cell receptors, chimeric antibody receptors, and other genetic manipulation aimed at improving their effectiveness as anti-cancer agents. Furthermore, the revolutionary role of checkpoint inhibitors and their potential in combination with other immunotherapeutic approaches or with standard chemo and radiation therapy are extensively discussed.

Related Products